{"id":802078,"date":"2025-01-17T09:03:41","date_gmt":"2025-01-17T14:03:41","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\/"},"modified":"2025-01-17T09:03:41","modified_gmt":"2025-01-17T14:03:41","slug":"natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\/","title":{"rendered":"Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year<\/b><\/p>\n<p>AUSTIN, Texas&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.natera.com%2F&amp;esheet=54181890&amp;newsitemid=20250117320339&amp;lan=en-US&amp;anchor=Natera%2C+Inc.&amp;index=1&amp;md5=429e87b8ac1c99c7ea9307efaa49f5d9\">Natera, Inc.<\/a> (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its CEO, Steve Chapman, has been selected as one of the top healthcare technology CEOs for 2024, as determined by <i>Healthcare Technology Report<\/i>. Chapman was also named \u201cBioTechnology Innovator of the Year\u201d in 2024, in the fourth annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough. These recognitions highlight Chapman\u2019s leadership at Natera, where he has served as CEO since Jan. 2019.<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20250117320339\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250117320339\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 480px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250117320339\/en\/2356100\/4\/Steve.jpg\" alt=\"Steve Chapman, CEO, Natera (Photo: Business Wire)\" \/><\/p>\n<p style=\"font-size:85%\">Steve Chapman, CEO, Natera (Photo: Business Wire)<\/p>\n<\/div>\n<p>\nDuring Chapman\u2019s 15-year tenure at Natera, the company has published more than 250 peer-reviewed papers and launched 20 products that have transformed patient care, including two of the fastest growing genetic tests of all time. The company\u2019s suite of products includes the Signatera\u2122 oncology test for molecular residual disease; the Prospera\u2122 transplant assessment test; and the highly differentiated Panorama\u2122 test serving patients in the non-invasive prenatal testing market.<\/p>\n<p>\n\u201cI want to congratulate every team member at Natera for their contributions in helping us achieve this award,\u201d said Steve Chapman, CEO. \u201cInnovation is core to our mission of transforming disease management for millions of patients worldwide, and we are honored to help individuals and families as they navigate some of life\u2019s most important healthcare journeys.\u201d<\/p>\n<p>\nThe annual awards program by <i>Healthcare Technology Report <\/i>features the top 50 CEOs at influential biotechnology and life sciences companies. These leaders have brought some of the most advanced healthcare solutions to market, leveraging keen business acumen while improving the patient care experience and outcomes.<\/p>\n<p>\nBioTech Breakthrough is a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products, and services around the globe. The mission of the annual awards program is to conduct the industry\u2019s most comprehensive analysis and evaluation of the world\u2019s top companies, solutions, and products in the life sciences and biotechnology markets today. This year\u2019s program attracted thousands of nominations from over 14 different countries throughout the world, serving as a global recognition platform that encourages bold ideas and solutions that will shape the future of biotechnology.<\/p>\n<p><b>Steve Chapman: Biographical Information<\/b><\/p>\n<p>\nSteve Chapman is the chief executive officer of Natera, a global leader in cell-free DNA and genetic testing in oncology, women\u2019s health, and organ health. He also serves on the company\u2019s board of directors.<\/p>\n<p>\nChapman is a leading authority on the commercialization of genetic testing. Before his appointment as CEO in 2019, he held a number of other leadership positions at Natera including chief operating officer. Earlier in his career, he worked at Genzyme Genetics. He began his career as a researcher in the department of human genetics at the University of California Los Angeles (UCLA), where he designed arrays identifying SNPs associated with multiple sclerosis.<\/p>\n<p>\nChapman has been a guest on CNBC and other shows and podcasts to share more about Natera\u2019s impact on patient care in the field of personalized genetic testing and diagnostics. He is an author on multiple scientific papers.<\/p>\n<p>\nChapman graduated with honors and holds a B.S. in Microbiology, Immunology, and Molecular Genetics from UCLA.<\/p>\n<p><b>About Natera<\/b><\/p>\n<p>\nNatera\u2122 is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women\u2019s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera\u2019s tests are validated by more than 250 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.natera.com&amp;esheet=54181890&amp;newsitemid=20250117320339&amp;lan=en-US&amp;anchor=www.natera.com&amp;index=2&amp;md5=9f3e0f11b0dcc1f82ae276f4ee99f6aa\">www.natera.com<\/a>.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250117320339r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250117320339\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250117320339\/en\/<\/a><\/span><\/p>\n<p>\nInvestor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350, <a rel=\"nofollow\" href=\"mailto:investor@natera.com\">investor@natera.com<br \/>\n<\/a><br \/>Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., <a rel=\"nofollow\" href=\"mailto:pr@natera.com\">pr@natera.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America Texas<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Genetics Health Oncology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250117320339\/en\/1736351\/3\/Natera_floret_Logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250117320339\/en\/2356100\/3\/Steve.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">Steve Chapman, CEO, Natera (Photo: Business Wire)<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its CEO, Steve Chapman, has been selected as one of the top healthcare technology CEOs for 2024, as determined by Healthcare Technology Report. Chapman was also named \u201cBioTechnology Innovator of the Year\u201d in 2024, in the fourth annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough. These recognitions highlight Chapman\u2019s leadership at Natera, where he has served as CEO since Jan. 2019. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20250117320339\/en\/ Steve Chapman, CEO, Natera (Photo: Business Wire) During Chapman\u2019s 15-year tenure &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-802078","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its CEO, Steve Chapman, has been selected as one of the top healthcare technology CEOs for 2024, as determined by Healthcare Technology Report. Chapman was also named \u201cBioTechnology Innovator of the Year\u201d in 2024, in the fourth annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough. These recognitions highlight Chapman\u2019s leadership at Natera, where he has served as CEO since Jan. 2019. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20250117320339\/en\/ Steve Chapman, CEO, Natera (Photo: Business Wire) During Chapman\u2019s 15-year tenure &hellip; Continue reading &quot;Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-17T14:03:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250117320339\/en\/2356100\/4\/Steve.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year\",\"datePublished\":\"2025-01-17T14:03:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\\\/\"},\"wordCount\":723,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250117320339\\\/en\\\/2356100\\\/4\\\/Steve.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\\\/\",\"name\":\"Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250117320339\\\/en\\\/2356100\\\/4\\\/Steve.jpg\",\"datePublished\":\"2025-01-17T14:03:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250117320339\\\/en\\\/2356100\\\/4\\\/Steve.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250117320339\\\/en\\\/2356100\\\/4\\\/Steve.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\/","og_locale":"en_US","og_type":"article","og_title":"Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year - Market Newsdesk","og_description":"Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its CEO, Steve Chapman, has been selected as one of the top healthcare technology CEOs for 2024, as determined by Healthcare Technology Report. Chapman was also named \u201cBioTechnology Innovator of the Year\u201d in 2024, in the fourth annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough. These recognitions highlight Chapman\u2019s leadership at Natera, where he has served as CEO since Jan. 2019. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20250117320339\/en\/ Steve Chapman, CEO, Natera (Photo: Business Wire) During Chapman\u2019s 15-year tenure &hellip; Continue reading \"Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\/","og_site_name":"Market Newsdesk","article_published_time":"2025-01-17T14:03:41+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250117320339\/en\/2356100\/4\/Steve.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year","datePublished":"2025-01-17T14:03:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\/"},"wordCount":723,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250117320339\/en\/2356100\/4\/Steve.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\/","name":"Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250117320339\/en\/2356100\/4\/Steve.jpg","datePublished":"2025-01-17T14:03:41+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250117320339\/en\/2356100\/4\/Steve.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250117320339\/en\/2356100\/4\/Steve.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/natera-ceo-steve-chapman-recognized-as-a-2024-top-healthcare-technology-ceo-and-biotechnology-innovator-of-the-year\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/802078","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=802078"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/802078\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=802078"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=802078"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=802078"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}